{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T13:40:29Z","timestamp":1783431629349,"version":"3.54.6"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,1,25]],"date-time":"2021-01-25T00:00:00Z","timestamp":1611532800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,25]],"date-time":"2021-01-25T00:00:00Z","timestamp":1611532800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s00467-020-04906-8","type":"journal-article","created":{"date-parts":[[2021,1,25]],"date-time":"2021-01-25T13:06:08Z","timestamp":1611579968000},"page":"1025-1028","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Plasma intact fibroblast growth factor 23 level is a useful tool for diagnostic approach of renal hypophosphatemia"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2865-2193","authenticated-orcid":false,"given":"Marina","family":"Giralt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Chocron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8925-3172","authenticated-orcid":false,"given":"Roser","family":"Ferrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1763-1098","authenticated-orcid":false,"given":"Gema","family":"Ariceta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,25]]},"reference":[{"key":"4906_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2019.01.006","volume":"103","author":"J Bacchetta","year":"2020","unstructured":"Bacchetta J, Bardet C, Pri\u00e9 D (2020) Physiology of FGF23 and overview of genetic diseases associated with renal phosphate wasting. Metabolism 103:153865. https:\/\/doi.org\/10.1016\/j.metabol.2019.01.006","journal-title":"Metabolism"},{"key":"4906_CR2","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/ng1095-130","volume":"11","author":"F Francis","year":"1995","unstructured":"Francis F, Hennig S, Korn B, Reinhardt R, de Jong P, Poustka A, Lehrach H, Rowe PSN, Goulding JN, Summerfield T, Mountford R, Read AP, Popowska E, Pronicka E, Davies KE, O'Riordan JLH, Econs MJ, Nesbitt T, Drezner MK, Oudet C, Pannetier S, Hanauer A, Strom TM, Meindl A, Lorenz B, Cagnoli B, Mohnike KL, Murken J, Meitinger T (1995) A gene (PEX) with homologies to endopeptidases is mutated in patients with X\u2013linked hypophosphatemic rickets. Nat Genet 11:130\u2013136. https:\/\/doi.org\/10.1038\/ng1095-130","journal-title":"Nat Genet"},{"key":"4906_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2019.03.009","volume":"103","author":"A Rothenbuhler","year":"2020","unstructured":"Rothenbuhler A, Schnabel D, H\u00f6gler W, Linglart A (2020) Diagnosis, treatment-monitoring and follow-up of children and adolescents with X-linked hypophosphatemia (XLH). Metabolism 103:153892. https:\/\/doi.org\/10.1016\/j.metabol.2019.03.009","journal-title":"Metabolism"},{"key":"4906_CR4","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s00439-009-0631-z","volume":"125","author":"C Gaucher","year":"2009","unstructured":"Gaucher C, Walrant-Debray O, Nguyen T-M, Esterle L, Garab\u00e9dian M, Jehan F (2009) PHEX analysis in 118 pedigrees reveals new genetic clues in hypophosphatemic rickets. Hum Genet 125:401\u2013411. https:\/\/doi.org\/10.1007\/s00439-009-0631-z","journal-title":"Hum Genet"},{"key":"4906_CR5","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.jbspin.2019.01.012","volume":"86","author":"AS Lambert","year":"2019","unstructured":"Lambert AS, Zhukouskaya V, Rothenbuhler A, Linglart A (2019) X-linked hypophosphatemia: management and treatment prospects. Joint Bone Spine 86:731\u2013738. https:\/\/doi.org\/10.1016\/j.jbspin.2019.01.012","journal-title":"Joint Bone Spine"},{"key":"4906_CR6","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1172\/JCI72829","volume":"124","author":"TO Carpenter","year":"2014","unstructured":"Carpenter TO, Imel EA, Ruppe MD, Weber TJ, Klausner MA, Wooddell MM, Kawakami T, Ito T, Zhang X, Humphrey J, Insogna KL, Peacock M (2014) Randomized trial of the anti-FGF23 antibody KRN23 in X-linked hypophosphatemia. J Clin Invest 124:1587\u20131597. https:\/\/doi.org\/10.1172\/JCI72829","journal-title":"J Clin Invest"},{"key":"4906_CR7","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1016\/j.bone.2012.02.135","volume":"50","author":"O Andrukhova","year":"2012","unstructured":"Andrukhova O, Zeitz U, Goetz R, Mohammadi M, Lanske B, Erben RG (2012) FGF23 acts directly on renal proximal tubules to induce phosphaturia through activation of the ERK1\/2\u2013SGK1 signaling pathway. Bone 50:S49\u2013S50. https:\/\/doi.org\/10.1016\/j.bone.2012.02.135","journal-title":"Bone"},{"key":"4906_CR8","doi-asserted-by":"publisher","first-page":"5520","DOI":"10.1073\/pnas.1402218111","volume":"111","author":"VS Tagliabracci","year":"2014","unstructured":"Tagliabracci VS, Engel JL, Wiley SE, Xiao J, Gonzalez DJ, Appaiah HN, Koller A, Nizet V, White KE, Dixon JE (2014) Dynamic regulation of FGF23 by Fam20C phosphorylation, GalNAc-T3 glycosylation, and furin proteolysis. Proc Natl Acad Sci 111:5520\u20135525. https:\/\/doi.org\/10.1073\/pnas.1402218111","journal-title":"Proc Natl Acad Sci"},{"key":"4906_CR9","doi-asserted-by":"publisher","unstructured":"Haffner D, Emma F, Eastwood DM, Duplan MB, Bacchetta J, Schnabel D, Wicart P, Bockenhauer D, Santos F, Levtchenko E, Harvengt P, Kirchhoff M, Di Rocco F, Chaussain C, Brandi ML, Savendahl L, Briot K, Kamenicky P, Rejnmark L, Linglart A (2019) Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia. Nat Rev Nephrol 15:435\u2013455. https:\/\/doi.org\/10.1038\/s41581-019-0152-5","DOI":"10.1038\/s41581-019-0152-5"},{"key":"4906_CR10","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1007\/s00223-017-0307-y","volume":"101","author":"JC Souberbielle","year":"2017","unstructured":"Souberbielle JC, Pri\u00e9 D, Piketty ML, Rothenbuhler A, Delanaye P, Chanson P, Cavalier E (2017) Evaluation of a new fully automated assay for plasma intact FGF23. Calcif Tissue Int 101:510\u2013518. https:\/\/doi.org\/10.1007\/s00223-017-0307-y","journal-title":"Calcif Tissue Int"},{"key":"4906_CR11","doi-asserted-by":"publisher","unstructured":"Ewert A, Leifheit-Nestler M, Hohenfellner K, B\u00fcscher A, Kemper MJ, Oh J, Billing H, Thumfart J, Stangl G, Baur AC, F\u00f6ller M, Feger M, Weber LT, Acham-Roschitz B, Arbeiter K, T\u00f6nshoff B, Zivicnjak M, Haffner D (2020) Bone and mineral metabolism in children with nephropathic cystinosis compared to other CKD entities. J Clin Endocrinol Metab 105:dgaa267. https:\/\/doi.org\/10.1210\/clinem\/dgaa267\/5837710","DOI":"10.1210\/clinem\/dgaa267\/5837710"},{"key":"4906_CR12","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1681\/ASN.2005010052","volume":"16","author":"O Gutierrez","year":"2005","unstructured":"Gutierrez O, Isakova T, Rhee E, Shah A, Holmes J, Collerone G, J\u00fcppner H, Wolf M (2005) Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease. J Am Soc Nephrol 16:2205\u20132215. https:\/\/doi.org\/10.1681\/ASN.2005010052","journal-title":"J Am Soc Nephrol"},{"key":"4906_CR13","doi-asserted-by":"publisher","first-page":"3144","DOI":"10.1210\/jc.2006-0021","volume":"91","author":"DM Antoniucci","year":"2006","unstructured":"Antoniucci DM, Yamashita T, Portale AA (2006) Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men. J Clin Endocrinol Metab 91:3144\u20133149. https:\/\/doi.org\/10.1210\/jc.2006-0021","journal-title":"J Clin Endocrinol Metab"},{"key":"4906_CR14","doi-asserted-by":"publisher","unstructured":"Carpenter TO, Insogna KL, Zhang JH, Ellis B, Nieman S, Simpson C, Olear E, Gundberg CM (2010) Circulating levels of soluble klotho and FGF23 in X-linked hypophosphatemia: circadian variance, effects of treatment, and relationship to parathyroid status. J Clin Endocrinol Metab 95:E352-357. https:\/\/doi.org\/10.1210\/jc.2010-0589","DOI":"10.1210\/jc.2010-0589"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-020-04906-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-020-04906-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-020-04906-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,26]],"date-time":"2021-02-26T12:35:14Z","timestamp":1614342914000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-020-04906-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,25]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["4906"],"URL":"https:\/\/doi.org\/10.1007\/s00467-020-04906-8","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,25]]},"assertion":[{"value":"1 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Ethical Committee of the University Hospital Vall d\u2019Hebron, Barcelona, Spain.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consents\/assents as applicable were obtained from all the patients included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}}]}}